We are monitoring the impact of COVID-19 on Europe Breast Cancer Screening Market Get in touch with us for detailed analysis Know More
Pulished Date November, 2021
ID: 12369
Share on
Share on

Europe Breast Cancer Screening Market Research Report - Segmented By Material Type, Application, End-user & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of EU) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: November, 2021
ID: 12369
Pages: 100

Europe Breast Cancer Screening Market Size (2021 to 2026)

The breast cancer screening market in the European region is estimated to be growing at a CAGR of 4.41% from 2021 to 2026 and worth USD 518.11 million in 2021 and USD 642.94 million by 2026.

Breast cancer is the second most common cancer in women across the globe, with over 2 million new cases detected in 2019. The increasing incidence of breast cancer, the presence of leading players in the European breast cancer screening market, and solid research and development are significant factors driving the market's growth. Approximately 58,000 women and 380 men are diagnosed with breast cancer each year in the UK. In Englan, nearly 47,000 people are diagnosed with breast cancer each year. In Scotland, around 4,800 people are diagnosed with breast cancer each year. In Wales, approximately 2,900 people are diagnosed with breast cancer each year. According to EUROPA DONNA, the European Coalition Against Breast Cancer, breast cancer is the most common cancer among women in the European region with a prevalence of 565,500 in 2019, and 1 in 8 women in the European nations will develop breast cancer before the age of 85. Breast cancer, therefore, affects many women during their peak years, which is likely to drive market growth during the forecast period.

The increasing number of breast cancer cases is mainly due to unhealthy habits like smoking, unhealthy diet or infections, and positive family history. This increases the demand for gold standard mammograms, while blood and laboratory tests and other diagnostic imaging tests are also gaining popularity. The Globocan report indicates that in 2019, 32,900 new breast cancer cases were discovered, and 6,500 deaths from breast cancer were reported in Spain. Due to this increase in breast cancer cases in Spain, there is an increasing need for routine screening and advancement in technologies. Several local governments and other healthcare organizations around Europe are conducting free breast screening camps and education to increase the prognosis for breast cancer patients with early diagnosis.

However, the high cost associated with breast cancer screening is slowing the growth of the market. In addition, certain risks associated with using X-ray machines and radiations may limit the uptake of breast cancer screening procedures in the region.

This research report on the European breast cancer screening market has been segmented and sub-segmented into the following categories.

By Type:

  • Imaging
  • Biopsy
  • Genomic Tests
  • Blood Tests
  • Others

By Product:

  • Platform-based Products
    • Next-generation Sequencing
    • Microarrays
    • PCR
    • Others
  • Instrument-based Products
    • Imaging
    • Biopsy

By Application:

  • Screening
  • Diagnostic and Predictive
  • Prognostic
  • Research

By End-user:

  • Hospitals & Clinics
  • Diagnostic Centers and Medical Laboratories
  • Others

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Germany dominated the European breast cancer screening market and accounted for the largest revenue share of 29% in 2020. According to the Globocan report, the total number of breast cancer cases in Germany recorded was approximately 72,000 in 2019, and around 19,400 breast cancer deaths have been reported. Breast cancer is one of the most common types of cancer in Germany. The significant factors contributing to the dominance of this region are the presence of substantial players coupled with advanced research and development in diagnostic and screening techniques, high patient awareness, and favorable reimbursement policies.

In high-income European countries, such as Denmark, breast cancer mortality has declined over the past 20 to 20 years, from a rate of 55 per 100,000 in early 1960 to a steady decline of 35 per 100,000 in 2017.

In the United Kingdom, the regional market is expected to experience the highest CAGR during the forecast period owing to the increasing incidence of breast cancer, improving reimbursement guidelines, well-developed healthcare infrastructure, and the adoption of the latest technologies. According to statistics from Cancer Research UK, there were 55,200 new cases of breast cancer and 11,450 cancer deaths between 2016 and 2018. In addition, statistics state that nearly 152 new breast cancer cases are diagnosed in women every day. Although according to cancer research UK, Breast cancer in men is not as common in the UK, there were around 392 new cases in 2018.

KEY MARKET PARTICIPANTS:

Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc., Siemens AG, NanoString Technologies Inc., C. R. Bard Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc and Quest Diagnostics Incorporated are predicted to account for the majority of the share in the European breast cancer screening market during the forecast period.

  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions                                            
    4. Base Currency, Base Year and Forecast Periods                                                     
  2. Research Methodology                                                                    
    1. Analysis Design                                                   
    2. Research Phases                                                 
      1. Secondary Research                                       
      2. Primary Research                              
      3. Data Modelling                                 
      4. Expert Validation                              
    3. Study Timeline                                                    
  3. Report Overview                                                                 
    1. Executive Summary                                           
    2. Key Inferences                                                  
  4. Market Dynamics                                                                
    1. Impact Analysis                                                   
      1. Drivers                                  
      2. Restraints                              
      3. Opportunities                                    
    2. Regulatory Environment                                                  
    3. Technology Timeline & Recent Trends                                                      
  5. Competitor Benchmarking Analysis                                                             
    1. Key Player Benchmarking                                                
      1. Market share analysis                                    
      2. Products/Service                              
      3. Regional Presence                            
    2. Mergers & Acquisition Landscape                                                
    3. Joint Ventures & Collaborations                                                  
  6. Market Segmentation                                                                       
    1. Breast Cancer Screening Market, By Type
      1. Imaging
      2. Biopsy
      3. Genomic Tests
      4. Blood Tests
      5. Others
      6. Market Size Estimations & Forecasts (2021-2026)                               
      7. Y-o-Y Growth Rate Analysis                                         
      8. Market Attractiveness Index         
    2.  Breast Cancer Screening Market, By Product
      1. Platform-based Products
        1. Next-generation Sequencing
        2. Microarrays
        3. PCR
        4. Others
      2. Instrument-based Products
        1. Imaging
        2. Biopsy
      3. Market Size Estimations & Forecasts (2021-2026)                               
      4. Y-o-Y Growth Rate Analysis                                         
      5. Market Attractiveness Index         
    3.  Breast Cancer Screening Market, By Application
      1. Screening
      2. Diagnostic and Predictive
      3. Prognostic
      4. Research
      5. Market Size Estimations & Forecasts (2021-2026)                              
      6. Y-o-Y Growth Rate Analysis                                        
      7. Market Attractiveness Index    
    4. Breast Cancer Screening Market, By End-User
      1. Hospitals & Clinics
      2. Diagnostic Centers and Medical Laboratories
      3. Others
      4. Market Size Estimations & Forecasts (2021-2026)                              
      5. Y-o-Y Growth Rate Analysis                                         
      6. Market Attractiveness Index    
  7. Geographical Landscape                                                                  
    1. Europe                                                   
      1. By Country                                         
        1. UK                        
        2. France                 
        3. Germany                          
        4. Spain                   
        5. Italy                     
        6. Rest of Europe
  8. Key Player Analysis                                                             
    1. Abbott Laboratories
      1. Business Description                                      
      2. Products/Service                              
      3. Financials                             
      4. SWOT Analysis                                  
      5. Recent Developments                                    
      6. Analyst Overview                              
    2. Myriad Genetics Inc.
    3. Hologic Inc.
    4. Koninklijke Philips N.V.
    5. Fujifilm Holdings Corporation
    6. GE Healthcare
    7. Thermo Fischer Scientific Inc.
    8. Siemens AG
    9. NanoString Technologies Inc.
    10. C. R. Bard Inc.
    11. Gamma Medica Inc.
    12. Aurora Imaging Technology Inc.
    13. Leica Biosystems Nussloch GmbH
    14. bioTheranostics Inc.
    15. Bio-Rad Laboratories Inc.
    16. Illumina Inc.
    17. Biocept Inc.
    18. Epigenomics AG
    19. AstraZeneca plc
    20. Quest Diagnostics Incorporated
  9. Market Outlook & Investment Opportunities
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of type, application and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Europe Breast Cancer Screening Market, By Type, From 2021 to 2026 (USD Million)
  2. Europe Imaging Market, By Region, From 2021 to 2026 (USD Million)
  3. Europe Biopsy Market, By Region, From 2021 to 2026 (USD Million)
  4. Europe Genomic Tests Market, By Region, From 2021 to 2026 (USD Million)
  5. Europe Blood Tests Market, By Region, From 2021 to 2026 (USD Million)
  6. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  7. Europe Breast Cancer Screening Market, By Application, From 2021 to 2026 (USD Million)
  8. Europe Screening Market, By Region, From 2021 to 2026 (USD Million)
  9. Europe Diagnostic and Predictive Market, By Region, From 2021 to 2026 (USD Million)
  10. Europe Prognostic Market, By Region, From 2021 to 2026 (USD Million)
  11. Europe Research Market, By Region, From 2021 to 2026 (USD Million)
  12. Europe Breast Cancer Screening Market, By Product, From 2021 to 2026 (USD Million)
  13. Europe Platform-based Products Market, By Region, From 2021 to 2026 (USD Million)
  14. Europe Instrument-based Products Market, By Region, From 2021 to 2026 (USD Million)
  15. Europe Breast Cancer Screening Market, By End-user, From 2021 to 2026 (USD Million)
  16. Europe Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Million)
  17. Europe Diagnostic Centers and Medical Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  18. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  19. U.K. Breast Cancer Screening Market, By Type, From 2021 to 2026 (USD Million)
  20. U.K. Breast Cancer Screening Market, By Application, From 2021 to 2026 (USD Million)
  21. U.K. Breast Cancer Screening Market, By Product, From 2021 to 2026 (USD Million)
  22. U.K. Breast Cancer Screening Market, By End-user, From 2021 to 2026 (USD Million)
  23. Germany Breast Cancer Screening Market, By Type, From 2021 to 2026 (USD Million)
  24. Germany Breast Cancer Screening Market, By Application, From 2021 to 2026 (USD Million)
  25. Germany Breast Cancer Screening Market, By Product, From 2021 to 2026 (USD Million)
  26. Germany Breast Cancer Screening Market, By End-user, From 2021 to 2026 (USD Million)
  27. France Breast Cancer Screening Market, By Type, From 2021 to 2026 (USD Million)
  28. France Breast Cancer Screening Market, By Application, From 2021 to 2026 (USD Million)
  29. France Breast Cancer Screening Market, By Product, From 2021 to 2026 (USD Million)
  30. France Breast Cancer Screening Market, By End-user, From 2021 to 2026 (USD Million)
  31. Italy Breast Cancer Screening Market, By Type, From 2021 to 2026 (USD Million)
  32. Italy Breast Cancer Screening Market, By Application, From 2021 to 2026 (USD Million)
  33. Italy Breast Cancer Screening Market, By Product, From 2021 to 2026 (USD Million)
  34. Italy Breast Cancer Screening Market, By End-user, From 2021 to 2026 (USD Million)
  35. Spain Breast Cancer Screening Market, By Type, From 2021 to 2026 (USD Million)
  36. Spain Breast Cancer Screening Market, By Application, From 2021 to 2026 (USD Million)
  37. Spain Breast Cancer Screening Market, By Product, From 2021 to 2026 (USD Million)
  38. Spain Breast Cancer Screening Market, By End-user, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample